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INTRODUCTION: Gastric outlet obstruction is characterized by the retention of gastric contents. Removal
of gastric contents is an important part of the treatment strategy. The use of a nasogastric tube alone can
result in inadequate removal of gastric contents. We treated a patient with advanced gastric cancer and
gastric outlet obstruction with pancrelipase to aid in the removal of gastric contents.
PRESENTATION OF CASE: The patient is an 81-year-oldmanwith a Type 3 gastric cancer nearly circumfer-
entially involving the antrum, resulting in gastric outlet obstruction. A nasogastric tube was placed for
four days, but drainage of gastric contents was inadequate. Pancrelipase was then given orally for four
days, and gastric contents were evacuated. The patient underwent distal gastrectomy with Roux-en-Y
reconstruction and was discharged from the hospital on postoperative day 14.
DISCUSSION: This report suggests that pancrelipase may be beneﬁcial in the treatment of patients with
gastric outlet obstruction.
CONCLUSION: Pancrelipase allowed gastric contents to be evacuated in a short period of time in a patient
with gastric outlet obstruction.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Background
Gastric outlet obstruction is common in patients with advanced
gastric cancer, duodenal cancer, gallbladder cancer, cholangiocar-
cinoma, and pancreatic cancer. Gastric outlet obstruction is usually
treated by gastrectomy, bypass, or stent placement to allow oral
intake [1–4]. Since patients with gastric outlet obstruction have
retention of gastric contents, a nasogastric tube is often used to
remove the residual material [5]. However, undigested food can be
difﬁcult to removewith a nasogastric tube alone, and large volumes
of material often remain in the stomach.
We treated a patient with gastric cancer and resulting gastric
outlet obstruction with pancrelipase. The gastric contents were
then readily removed. To our knowledge, the use of pancrelipase in
patientswith pyloric obstruction has not been reported previously,
and this may be of use in the care of such patients.
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2. Case presentation
The patient is an 81-year-oldmanwho presentedwith a history
of decreased oral intake, but did not report vomiting. Difﬁculty in
oral intake persisted for seven months, and the patient was aware
of having lost four kg of weight. The patient had a 20-year history
of hypertension. Upper gastrointestinal endoscopy revealed gastric
cancer, and the patient was referred for further treatment. Com-
puted tomography showed marked retention of gastric contents
(502mL on volumetric measurement) (Fig. 1), and thickening of
the pyloric region. The peri-gastric fat was fuzzy, suggesting tumor
invasion beyond the serosa. Lymph nodes at stations 12a and 8a
were enlarged.
A 16-French nasogastric tubewas inserted, and gastric contents
were aspirated. Thedrainage volume from thenasogastric tubewas
1080 and 600ml on the ﬁrst two hospital days. On the second hos-
pital day, upper gastrointestinal endoscopy was performed (Fig.2).
The stomach still contained a large amount of undigested food. A
Type3 semi-circumferential tumor involving theanteriorwall from
the antrum to the pylorus was present. There was a tight stenotic
area, but an endoscope could be passed through the site. Clinical
stage IIIB, T4a(SE)N2M0 gastric cancer was diagnosed (according
http://dx.doi.org/10.1016/j.ijscr.2015.05.023
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. (A) A computed tomographic scan showing the retention of a large volume of gastric contents on the ﬁrst hospital day (502mL). (B) On the fourth hospital day, the
volume of gastric contents had decreased, but a large volume of food debris remained (156mL).
Fig. 2. (A) An endoscopic image showing the retention of a large volume of food debris in the stomach. Aspiration was difﬁcult . (B) A semi-circumferential tumor arising
mainly in the anterior wall of the antrum.
to the 14th edition of the Japanese Classiﬁcation of Gastric Cancer)
[6], and distal gastrectomy was planned.
Gastric aspiration was continued using the nasogastric tube.
Computed tomography scan on the fourth hospital day revealed a
large residual volume of gastric contents (156mL). Therefore, pan-
crelipasewasgivenorally inadailydoseof1800mg in threedivided
doses per day. After each dose of pancrelipase, the nasogastric tube
was clamped for four hours and then released to aspirate the gas-
tric contents. Since pancrelipase is an enteric-coated preparation,
a proton pump inhibitor, lansoprazole, was also administered to
maintain a neutral intra-gastric pH. The patient was fully informed
that it was unclear whether pancrelipase would be effective, and
written informed consent was obtained. There were no adverse
reactions related to treatment with pancrelipase. The drainage
volume from nasogastric tube during administration of pancreli-
pase was 450, 250 and 115ml, each day. On the eighth hospital
day, surgery was performed. Intraoperative examination showed
peritoneal dissemination of tumor, and stage IV cancer sT4a(SE)
NxM1(P1) was diagnosed. Due to the history of decreased oral
intake, a palliative distal gastrectomy was performed with a Roux-
en-Y reconstruction.Macroscopic residual tumor (R2)was present.
The operative time was 3h. 25min., with an estimated blood loss
of 100mL.
A type 3 cancer involving four ﬁfths of the circumference of
the anterior wall of the lesser curvature of the antrum (Fig. 3) was
found. The remainder of the gastric body was nearly normal, with
no edematous changes. Only one remaining fruit seed was found
Fig. 3. Histopathological specimens obtained by distal gastrectomy, showing
advanced gastric cancer arising in the anterior wall of the antrum. Only one seed of
fruit remained in the stomach.
Gunma
in the stomach, with no other residual food particles. The post-
operative course was unremarkable, and oral intake resumed. The
patientwas discharged from the hospital on the 14th postoperative
day and is scheduled to receive chemotherapy.
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3. Discussion
In this patient, treatment with pancrelipase promoted dis-
solution of gastric contents, allowing the contents to be nearly
completely aspirated. This suggests that pancrelipasemaybeuseful
in patients with gastric outlet obstruction to facilitate preoperative
removal of retained material in an obstructed stomach.
In patients with gastric outlet obstruction, only gastric juice
promotes digestion of gastric contents. The lipase and pepsin in
gastric juice enables the breakdown of proteins and lipids [7]. In
the presence of gastric outlet obstruction, however, large amounts
of food debris are frequently retained and are difﬁcult to remove
with a nasogastric tube alone. In contrast, in patients with small
bowel obstruction, gastric contents can be removed with a naso-
gastric tube [8]. The difference between gastric outlet obstruction
and small bowel obstruction is exposure to pancreatic enzymes.
Pancreatic enzymes are thought to have an important role in the
digestion of food debris in the stomach. In patients with pancre-
atic exocrine dysfunction, digestive function can be improved by
supplementation with pancreatic enzymes [9,10]. In the present
patient, the administration of pancrelipase promoted the digestion
of food debris inadequately digested by gastric juice alone, thereby
allowing removal of gastric contents.
Surgery for gastric outlet obstruction has been reported to be
associated with not only major complications but also minor com-
plications [11]. Residual material in the stomach obstructs the
operative ﬁeld and may contribute to the development of compli-
cations. Since endoscopic treatment is associatedwith an increased
risk of aspiration pneumonia, it is important to decrease the vol-
ume of gastric contents before treatment. In this patient, the gastric
contents were nearly completely removed, contributing to a good
postoperative course.
Pancrelipase is as an enteric-coated preparation, because the
active ingredient is releasedatpH5.5 [12]. After intragastric admin-
istration in patients with gastric outlet obstruction, pancrelipase
may not be adequately activated at the low pH caused by gastric
juice. The concurrent use of a proton pump inhibitor resulted in the
maintenance of a high intra-gastric pH, potentially resulting in the
good response to pancrelipase.
Larger studies, including randomized, placebo-controlled clini-
cal trials, are needed to conﬁrm the effectiveness of pancrelipase in
patients with gastric outlet obstruction. This experience suggests
that pancrelipase may be effective as preoperative preparation in
these patients. Future studies are needed to investigate whether
pancrelipase is useful to facilitate the removal of gastric contents.
4. Conclusions
The use of pancrelipase allowed gastric contents to be success-
fully removed in a short period of time in a patient with gastric
outlet obstruction. Pancrelipase might be useful as a pretreatment
in patients with gastric outlet obstruction.
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